Federated Hermes’s Filana Therapeutics FLNA Stock Holding History

Federated Hermes’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$143K	Buy	119,952 +4,855	+4%	+$6.92K	﹤0.01%	1580
2026 Q1	$195K	Buy	115,097 +23,618	+26%	+$48.6K	﹤0.01%	1498
2025 Q4	$181K	Buy	91,479 +48,194	+111%	+$154K	﹤0.01%	1508
2025 Q3	$126K	Buy	43,285 +5,875	+16%	+$13.5K	﹤0.01%	1552
2025 Q2	$67.7K	Hold	37,410	–	–	﹤0.01%	1614
2025 Q1	$56.1K	Buy	37,410 +30,310	+427%	+$76.5K	﹤0.01%	1627
2024 Q4	$16.8K	Buy	+7,100	New	+$125K	﹤0.01%	1786
2022 Q4	–	Sell	-4,160	Closed	-$174K	–	2265
2022 Q3	$174K	Buy	4,160 +2,633	+172%	+$71.1K	﹤0.01%	1545
2022 Q2	$43K	Buy	+1,527	New	+$38.6K	﹤0.01%	1686
2021 Q3	–	Sell	-75	Closed	-$6K	–	2300
2021 Q2	$6K	Sell	75 -58	-44%	-$3.11K	﹤0.01%	2024
2021 Q1	$6K	Buy	+133	New	+$5.23K	﹤0.01%	2052
2017 Q2	–	Sell	-148	Closed	-$1K	–	2176
2017 Q1	$1K	Hold	148	–	–	﹤0.01%	2091
2016 Q4	$1K	Hold	148	–	–	﹤0.01%	2065
2016 Q3	$1K	Buy	+148	New	+$2.45K	﹤0.01%	2077
2014 Q3	–	Sell	-193	Closed	-$8K	–	2052
2014 Q2	$8K	Buy	+193	New	+$7.14K	﹤0.01%	1762

Other funds holding FLNA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Federated Hermes's FLNA Position: Q2 2026 in Review

Federated Hermes increased its Filana Therapeutics (FLNA) stake by 4.2% in Q2 2026, buying an estimated $6.92K and bringing the position to 119,952 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #1580.

Federated Hermes first reported a position in FLNA in Q2 2014 and has held it in 15 quarters since. The position peaked at $195K in Q1 2026. 84 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

Federated Hermes held 119,952 shares of Filana Therapeutics worth $143K as of Q2 2026.
Federated Hermes bought 4,855 Filana Therapeutics shares in Q2 2026, an estimated $6.92K.
Filana Therapeutics made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1580 holding.
Federated Hermes first reported a position in Filana Therapeutics in Q2 2014 and has held it in 15 quarters since.
Federated Hermes's Filana Therapeutics position peaked at $195K in Q1 2026.
84 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.